Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
4
currently held
Exits tracked
5
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capital
Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks agoCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminLauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month agoBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin8 companies matching
| Company | Sector | Geo | Investor | Entry | Hold | Status | Buyer | MOIC | |
|---|---|---|---|---|---|---|---|---|---|
Salfarm2 periods Polaris Private Equity V | Polaris | 2020 | 4yr | Active | – | – | |||
Salpharm Holding ApS Industri Udvikling V | Industri Udvikling | 2020 | 4yr | Exited 2024 | Polaris Private Equity | – | |||
Fertin Pharma EQT Mid Market Europe | EQT | 2017 | 4yr | Exited 2021 | Philip Morris International | – | |||
Egalet Sunstone Life Science Ventures III | Sunstone Life Science Ventures | 2010 | 4yr | Exited 2014 | – | – | |||
LifeCycle Pharma Nordic Biotech K/S | Nordic Biotech Advisors | 2002 | 4yr | Exited 2006 | – | – | |||
LEO Pharma Nordic Capital Fund X | Nordic Capital | 2021 | 5yr | Active | – | – | |||
Scantox Impilo Investment Pool 2 | Impilo | 2021 | 5yr | Active | – | – | |||
Xellia Pharmaceuticals Novo Holdings Principal Investments | Novo Holdings | 2013 | 13yr | Active | – | – |
Salfarm
Polaris Private Equity V
DenmarkSector
Pharma
InvestorPolaris
Entry
2020
Hold
4yr
Owners
2
Salpharm Holding ApS
Industri Udvikling V
DenmarkSector
Pharma
InvestorIndustri Udvikling
Entry
2020
Hold
4yr
Exit
2024
to Polaris Private Equity
Fertin Pharma
EQT Mid Market Europe
DenmarkSector
Pharma
InvestorEQT
Entry
2017
Hold
4yr
Exit
2021
to Philip Morris International
Egalet
Sunstone Life Science Ventures III
DenmarkSector
Pharma
InvestorSunstone Life Science Ventures
Entry
2010
Hold
4yr
Exit
2014
LifeCycle Pharma
Nordic Biotech K/S
DenmarkSector
Pharma
InvestorNordic Biotech Advisors
Entry
2002
Hold
4yr
Exit
2006
LEO Pharma
Nordic Capital Fund X
DenmarkSector
Pharma
InvestorNordic Capital
Entry
2021
Hold
5yr
Scantox
Impilo Investment Pool 2
DenmarkSector
Pharma
InvestorImpilo
Entry
2021
Hold
5yr
Xellia Pharmaceuticals
Novo Holdings Principal Investments
DenmarkSector
Pharma
InvestorNovo Holdings
Entry
2013
Hold
13yr